Correlation Between Scpharmaceuticals and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Protara Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Protara Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Protara Therapeutics
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Scpharmaceuticals and Protara is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Protara Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Protara Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.02 times less risky than Protara Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Protara Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 240.00 in Protara Therapeutics on August 29, 2024 and sell it today you would earn a total of 54.00 from holding Protara Therapeutics or generate 22.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Protara Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Protara Therapeutics |
Scpharmaceuticals and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Protara Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |